Johnson & Johnson commits $500 million investment over four years to help end the epidemics of HIV and TB

Johnson & Johnson announced it has committed to ensuring more than $500 million dedicated to world class research & development and delivery programs over the next four years to accelerate global efforts to eliminate HIV and TB by 2030.

To read the full press release, click here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Johnson & Johnson

Published: Oct. 4, 2019, 12:48 p.m.

Last updated: Oct. 8, 2019, 11:51 a.m.

Print Share